MYB and acute lymphoblastic leukemia: The EFS of MYB over-expressing cases were only 25% while the remaining patients were 71% (at 95% CI) as depicted in Fig. 2B. The remaining aberrantly expressed genes were not found to have any significant association with EFS, RR and OS in T-ALL patients.